3,3-dimethylbutan-1-ol has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, S; Gao, Q; Wang, RT; Wang, X; Wang, Y; Zhang, X | 1 |
1 other study(ies) available for 3,3-dimethylbutan-1-ol and Alzheimer Disease
| Article | Year |
|---|---|
Decreased levels of circulating trimethylamine N-oxide alleviate cognitive and pathological deterioration in transgenic mice: a potential therapeutic approach for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Behavior, Animal; Cognition; Disease Models, Animal; Gastrointestinal Microbiome; Hexanols; Hippocampus; Methylamines; Mice; Neuroprotective Agents; Oxidants | 2019 |